ORA Add to watchlist
$113.81 0.93 (-0.81%)
After Hours: $113.81 +0.00 (+0.00%)
Last updated: Apr 15, 2026 21:13
52-Week Range
$113.81
$69.78 $113.81 $132.58

Fundamentals Overview

Ormat Technologies, Inc. is in the middle of its 52-week range with premium valuation, trading relatively flat today.

Valuation premium

P/E 57.3 P/B 2.72 P/S 7

Profitability

Net margin 12.5%

Risk (Beta)

0.8 — in line vol

Earnings & growth

EPS $1.99 Rev +10.5% Profit +29.9% vs prior qtr

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell
Buy
Hold — 55% confidence Risk: Moderate Volatility — Beta 0.8. Diversify and only invest what you can afford to lose.

Supporting (Buy):

Sentiment improving (5 upgrades)

Pressures (Sell):

3M vs S&P 500: -5.1% · 3M vs Utilities sector: -12.5%

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap
$6.92B
P/E (TTM)
57.26
EPS (TTM)
$1.99
Dividend Yield
0.42%
52-Week Range
$69.78 - $132.58
Volume vs Avg
N/A
Beta
0.8

About

Ormat Technologies, Inc. engages in the geothermal and recovered energy power business in the United States, Indonesia, Kenya, Turkey, Chile, Guadeloupe, Guatemala, Ethiopia, New Zealand, Honduras, and internationally. It operates through three segments: Electricity, Product, and Energy Storage. The Electricity segment develops, builds, owns, and operates geothermal, solar photovoltaic, and recovered energy-based power plants; and sells electricity. The Product segment designs, manufactures, and...
Sector: Utilities
Headquarters: US
Employees: 1,512
IPO Date: Nov 2004
Website: www.ormat.com
Beta: 0.8 (Less volatile than market)

Ratings & Grades at a Glance

Overall rating: C+. Recent institutional grades: majority upgrades. Current institutional positions: Buy: 9, Equal Weight: 1, Hold: 2, Neutral: 6, Outperform: 4, Overweight: 8.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $-161.58; current price is $113.81. That’s a -242% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric Value
Valuation
P/E (TTM) 57.26
PEG (TTM) N/A
P/B (TTM) 2.72
P/S (TTM) 7
Liquidity & enterprise
Current Ratio (TTM) 0.81
Quick Ratio (TTM) 0.75
Cash Ratio (TTM) 0.38
Profitability
ROE (TTM) N/A
ROA (TTM) N/A
Revenue growth (YoY) N/A
Net margin (TTM) 12.52%
Gross margin (TTM) 27.56%
Operating margin (TTM) 13.95%
Debt to equity (TTM) N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for ORA.

Analyst Sentiment at a Glance

C+ Sentiment Improving
Buy 9Equal Weight 1Hold 2Neutral 6Outperform 4Overweight 8
5 upgrades, 1 downgrade
Price Target Consensus
Current $113.81
Median $136.00
Consensus $132.00
Low consensus $108.00
High consensus $143.00

Stock Grades (Institutions)

Institution Action Previous Grade New Grade Date
UBS maintain Buy Buy 2026-03-03
Barclays maintain Overweight Overweight 2026-03-02
Baird maintain Outperform Outperform 2026-02-27
Citigroup maintain Neutral Neutral 2026-02-18
Jefferies downgrade Buy Hold 2026-02-13
Oppenheimer maintain Outperform Outperform 2026-01-27
Barclays maintain Overweight Overweight 2026-01-15
TD Cowen upgrade Hold Buy 2026-01-09
Piper Sandler maintain Overweight Overweight 2025-12-18
UBS maintain Buy Buy 2025-11-07
Barclays maintain Overweight Overweight 2025-11-07
TD Cowen maintain Hold Hold 2025-11-05
Roth Capital maintain Buy Buy 2025-11-05
JP Morgan maintain Neutral Neutral 2025-11-05
JP Morgan maintain Neutral Neutral 2025-10-16
Jefferies maintain Buy Buy 2025-10-07
Piper Sandler upgrade Neutral Overweight 2025-09-17
Piper Sandler maintain Neutral Neutral 2025-08-19
Barclays maintain Overweight Overweight 2025-08-08
Roth Capital maintain Buy Buy 2025-08-05
Baird upgrade Neutral Outperform 2025-07-30
UBS maintain Buy Buy 2025-07-24
JP Morgan maintain Neutral Neutral 2025-07-22
Barclays maintain Overweight Overweight 2025-07-10
Barclays upgrade Equal Weight Overweight 2025-06-06
Barclays maintain Equal Weight Equal Weight 2025-05-08
Jefferies maintain Buy Buy 2025-03-25
JP Morgan maintain Neutral Neutral 2025-02-28
Jefferies upgrade Hold Buy 2025-02-20
Oppenheimer maintain Outperform Outperform 2024-11-08